Heart failure is the leading cause of death in Afib patients, but it doesn’t have to be.​
​
Join Dr. Richard Whitlock as he discusses how restoring Normal Sinus Rhythm (NSR) can improve quality of life and survival outcomes for Afib patients.​
​
Discover more about effective Afib treatment at actagainstafib.com.​
​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=cardiology&highlightedU…; target='_blank'>#cardiology</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=cardiacsurgery&highligh…; target='_blank'>#cardiacsurgery</a>

During Native American Heritage Month, we honor and celebrate the rich histories, cultures, and contributions of Native American and Indigenous peoples. At AtriCure, we are committed to fostering diversity and inclusivity in all that we do. Join us in recognizing the vibrant heritage and history that continues to shape our shared future. <a href='https://www.linkedin.com/feed/hashtag/?keywords=NativeAmericanHeritageM…; target='_blank'>#NativeAmericanHeritageMonth</a>

An eventful week announcing strong Q3 results &amp; an energized All-Employee Meeting. Grateful to Dr. David Newton for sharing insights on cardiac care, his hybrid program success <a href="https://twitter.com/myMemorial&quot; target="_blank">@myMemorial</a>, &amp; the future of hybrid therapy. <a href="https://twitter.com/hashtag/HybridTherapy?src=hashtag_click&quot; target="_blank">#HybridTherapy</a> <a href="https://twitter.com/hashtag/Electrophysiology?src=hashtag_click&quot; target="_blank">#Electrophysiology</a>

The new AtriClip® FLEX-Mini™ Device offers surgeons the same one-handed deployment capability we know works well while excluding the left atrial appendage with a closed-ended deployment.​
​
Learn more: <a href="https://t.co/m3ddhL3wkO&quot; target="_blank">https://t.co/m3ddhL3wkO</a&gt;

The new AtriClip® FLEX-Mini™ Device offers surgeons the same one-handed deployment capability we know works well while excluding the left atrial appendage with a closed-ended deployment.​
​
Learn more: <a href="https://okt.to/akgrvc&quot; target="_blank">https://okt.to/akgrvc</a&gt;

AtriCure is proud to partner with the Cincinnati Museum Center’s STEM Girls outreach programs, where we recently engaged with the next generation of innovators, scientists, and leaders. As a top workplace for women innovators, we are dedicated to highlighting careers in the medical device industry and empowering these young talents to create bright futures.​

Congratulations to Dr. Bruce Cannon and the <a href="https://twitter.com/NormanRegional&quot; target="_blank">@NormanRegional</a> team on their first case with cryoSPHERE® MAX! ​
Discover how Cryo Nerve Block is swapping pain for numbness in cardiac and thoracic patients: <a href="https://t.co/OspTMNeH5K&quot; target="_blank">https://t.co/OspTMNeH5K</a&gt;
​
<a href="https://twitter.com/hashtag/PainManagement?src=hashtag_click&quot; target="_blank">#PainManagement</a> <a href="https://twitter.com/hashtag/cryoNB?src=hashtag_click&quot; target="_blank">#cryoNB</a>

Congratulations to Dr. Bruce Cannon and the Norman Regional Health System team on their first case with cryoSPHERE® MAX! ​

Discover how Cryo Nerve Block is swapping pain for numbness in cardiac and thoracic patients: <a href="https://okt.to/AVHOa2&quot; target="_blank">https://okt.to/AVHOa2</a&gt;
<a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=cryoNB&highlightedUpdat…; target='_blank'>#cryoNB</a>

The CEASE-AF trial shows Hybrid ablation’s ~33% improvement in freedom from atrial arrhythmias* over 24 months for LSPAF**. Discover more about Hybrid AF™ Therapy at <a href="https://twitter.com/hashtag/AHA2024.?src=hashtag_click" target="_blank">#AHA2024.</a> Learn more here: <a href="https://t.co/Zs4xjdLb6U&quot; target="_blank">https://t.co/Zs4xjdLb6U</a&gt; ​

*Freedom from atrial arrhythmias (atrial fibrillation,… <a href="https://t.co/JWybCCHKUx&quot; target="_blank">https://t.co/JWybCCHKUx</a&gt;

The CEASE-AF trial highlights Hybrid ablation’s impressive long-term durability, showing a ~33% improvement in freedom from atrial arrhythmias* over 24 months for patients with long-standing persistent Afib**. Learn more about the compelling data behind Hybrid AF™ Therapy at <a href='https://www.linkedin.com/feed/hashtag/?keywords=AHA2024.&highlightedUpd…; target='_blank'>#AHA2024.</a>​
​
In the meantime, explore further here: <a href="https://okt.to/qy0uc3&quot; target="_blank">https://okt.to/qy0uc3</a&gt; ​
​
*Freedom from atrial arrhythmias (atrial fibrillation, atrial flutter, atrial tachycardia) off anti-arrhythmic drugs (AADs) except previously failed AADs at doses not exceeding those previously failed​​
**Persistent atrial fibrillation with enlarged left atrium and longstanding persistent Afib​​